Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide

Circulation Research

Volumn 81, Issue 1, 1997, Pages 42-52

  Bolli, Roberto ^a   Bhatti, Zulfiquar A ^b   Tang, Xian Liang ^b   Qiu, Yumin ^b   Zhang, Qin ^b   Guo, Yiru ^b   Jadoon, Asad K ^b  

^a University of Louisville School of Medicine   (United States)

^b NONE

Author keywords

L arginine; Myocardial ischemia reperfusion; Nitric oxide synthase; Nitrogen radicals; Oxygen radicals

Indexed keywords

ARGININE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGEN RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; STUNNED HEART MUSCLE;

EID: 0030955587     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.1.42     Document Type: Article

References (84)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
2. Jennings RB, Murry CE, Reimer KA. Preconditioning myocardium with ischemia. Cardiovasc Drugs Ther. 1991;5:933-938.
3. Downey JM. Ischemic preconditioning: nature's own curdioprotective intervention. Trends Cardiovasc Med. 1992;2:170-176.
4. Cohen MV, Downey JM. Preconditioning during ischemia. Cardiol Rev. 1995;3:137-149.
5. Van Winkle DM, Thornton JD, Downey DM. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coron Artery Dis. 1991;1;2:613-619.
6. Murry CE, Richard VJ, Jennings RB, Reimer KA. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol. 1991;260:H796-H804.
7. Cohen MV, Yang X-M, Downey JM. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res. 1994;74:998-1004.
8. Burckhartt B, Yang X-M, Tsuchida A, Mullane KM, Downey JM, Cohen MV. Acadesine extends the window of protection afforded by ischemic preconditioning in conscious rabbits. Cardiovasc Res. 1995;29:653-657.
9. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 1993;72:1293-1209.
10. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 1993;88:1264-1272.
11. Baxter GF, Marber MS, Patel VC, Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation. 1994;90:2993-3000.
12. Yang X-M, Baxter GF, Yellon DM, Fletcher JR, Downey JM, Cohen MV. Second window of protection in conscious rabbits. J Mol Cell Cardiol. 1994;27:A26. Abstract.
13. Qiu Y, Maldonado C, Tang XL, Bolli R. Late preconditioning against myocardial stunning in conscious rabbits. Circulation. 1995;92(suppl I):I-715. Abstract.
14. Sun J-Z, Tang X-L, Knowlton AA, Park SW, Qiu Y, Bolli R. Late preconditioning against myocardial stunning: an endogenous protective mechanism that confers resistance to postischcmic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest. 1995;95:388-403.
15. Sun J-Z, Tang X-L, Park SW, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 1996;97:562-576.
16. Tang X-L, Qiu Y, Park S-W, Sun J-Z, Kalya A. Bolli R. Timecourse of late preconditioning against myocardial stunning in conscious pigs. Circ Res. 1996;79:424-434.
17. Ping P, Zhang J, Qiu Y, Tang X-L, Manchikalapudi S, Bolli R. Repetitive episodes of myocardial ischemia and reperfusion induce translocation of protein kinase C epsilon isoform in conscious rabbits, which is associated with late preconditioning against myocardial stunning. Circulation. 1996;94(suppl I):I-660. Abstract.
18. Qiu Y, Tang X-L, Rizvi A, Manchikalapudi S, Maldonado C, Teschner S, Bolli R. Protein kinase C mediates late preconditioning against myocardial stunning in conscious rabbits. Circulation. 1996;94(suppl I):I-184. Abstract.
19. Teschner S, Qiu Y, Tang X-L, Maldonado C, Rizvi A, Manchikalapudi S, Bagri H, Jadoon A, Bolli R. Late preconditioning against myo- cardial stunning in conscious rabbits: a dose-related or an all-or-none phenomenon? Circulation. 1996;94(suppl I):I-423. Abstract.
20. Maldonado C, Qiu Y, Tang X-L, Cohen MV, Auchampach J, Bolli R. Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol. In press.
21. Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett. 1995;369:131-135.
22. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol. 1995;57:737-769.
23. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
24. Halliwell B. Superoxide, iron, vascular endothelium and reperfusion injury. Free Radic Res Commun. 1989;5:315-318.
25. Beckman JS, Beckman TW, Chen J, Marshall PA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990;87:1620-1624.
26. Zweier JL, Broderick R, Kuppusamy P, Thompson-Gorman S, Lutty GA. Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J Biol Chem. 1994;269:24156-24162.
27. Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence for peroxynitritemediated reperfusion injury. J Biol Chem. 1996;271:29223-29230.
28. Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol. 1992;5:834-842.
29. Morita K, Ihnken K, Buckberg GD, Sherman MP, Young HH, Ignarro LJ. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damace in cyanotic infantile hearts. J Clin Invest. 1994;93:2658-2666.
30. Depré C, Hue L. Cyclic GMP in the perfused rat heart: effect of ischemia, anoxia and nitric oxide synthase inhibitor. FEBS Lett. 1994;345:241-245.
31. Zweier JL, Wang P, Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem. 1995;270:304-307.
32. Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Tada M, Inoue M, Hori M, Kamada T. Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem Biophys Res Commun. 1995;211:370-374.
33. Yasmin W, Strynadka KD, Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res. 1997;33:422-432.
34. Hattler BG, Gorcsan J, Shah N, Oddis CV, Billiar TR, Simmons RL, Finkel MS. A potential role for nitric oxide in myocardial stunning. J Card Surg. 1994;9:425-429.
35. Kumura E, Kosaka H, Shiga T, Yoshimine T, Hayakawa T. Elevation of plasma nitric oxide end products during focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab. 1994;14:487-491.
36. Ischiropoulos H, Al-Mehdi AB, Fisher AB. Reactive species in ischemic rat lung injury: contribution of peroxynitrite. Am J Physiol. 1995;269:L158-L164.
37. Zhang Z-G, Chopp M, Bailey F, Malinski T. Nitric oxide changes in the rat brain after transient middle cerebral artery occlusion. J Neurol Sci. 1995;128:22-27.
38. ω-Nitro arginine (L-NARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro. Br J Pharmacol. 1990;176:219-223.
39. Chu A, Chambers DE, Lin CC, Kuehl WD, Palmer RMJ, Moncada S, Cobb FR. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest. 1991;87:1964-1968.
40. ω-Nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am J Physiol. 1991;260:H1299-H1306.
41. ω-Nitro-L-arpinine selectively inhibits vasodilator responses to acetylcholine and bradykinin in cats. Am J Physiol. 1991;260:H1025-H1029.
42. ω-Nitro-Larginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol. 1990;176:219-223.
43. Southan GJ, Szaho C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol. 1996;51:383-394.
44. G-Nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res. 1993;72: 387-395.
45. Li X-Y, McCay PB, Zughaib M, Jeroudi MO, Triana JF, Bolli R. Demonstration of free radical generation in the 'stunned' myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs. J Clin Invest. 1993;92: 1025-1041.
46. Triana JF, Li X-Y, Jamaluddin U, Thornby JI, Bolli R. Postischemic myocardial 'stunning': identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ Res. 1991;69:731-747.
47. Bolli R. Common methodological problems and artifacts associated with studies of myocardial stunning in vivo. Basic Res Cardiol. 1995;90:257-262.
48. Traystman RJ, Moore LE, Helfaer MA, Davis S, Banasiak K, Williams M, Hurn PD. Nitro-L-arginine analogues: dose- and time-related nitric oxide synthase inhibition in brain. Stroke. 1995;26: 864-869.
49. Liu J-L, Murakami H, Zucker IH. Effects of NO on baroreflex control of heart rate and renal nerve activity in conscious rabbits. Am J Physiol. 1996;39:R1361-R1370.
50. Bolli R, Zhu WX, Thornby JI, O'Neitt PG, Roberts R. Time-course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol. 1988;254:H102-H114.
51. Sekili S, McCay PB, Li X-Y, Zughaib M, Sun J-Z, Tang X-L, Thornby JI, Bolli R. Direct evidence that the hydroxyl radical plays a pathogonetic role in myocardial 'stunning' in the conscious dog and that stunning can be markedly attenuated without subsequent adverse effects. Circ Res. 1993;73:705-723.
52. Bolli R, Zughaib M, Li X-Y, Sun J-Z, Triana JF, McCay PB. Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function: a pathophysiological basis for chronic myocardial 'stunning.' J Clin Invest. 1995;96:1066-1084.
53. SAS Institute. SAS/STAT User's Guide, Release 6.03 Edition. Cary, NC: SAS Institute; 1988:675-712.
54. Reinhart GA, Lohmeier TE, Mizelle HL. Temporal influence of the renal nerves on renal excretory function during chronic inhibition of nitric oxide synthesis. Hypertension. 1997;29:199-204.
55. Vatner SF, Braunwald E. Cardiovascular control mechanisms in the conscious state. N Engl J Med. 1975;29:970-976.
56. Hasebe N, Shen YT, Vatner SF. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation. 1993;88:2862-2871.
57. Vegh A, Szekeres L, Parratt J. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol. 1992;107:648-652.
58. Vegh A, Papp JG, Szekeres, Parratt J. The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning. Br J Pharmacol. 1992;107:910-911.
59. Vegh A, Papp JG, Szekeres L, Parratt JR. Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs. Br J Pharmacol. 1993;110:18-19.
60. 2 receptors. Br J Pharmacol. 1994;113:1167-1172.
61. Hartman JC, Houshyar H, Leva SC, Wall TM. A role for nitricoxide in myocardial ischemic preconditioning. Circulation. 1995;92(suppl I):I-716. Abstract.
62. Lu H-R, Remeysen P, De Clerck F. Does the antiarrhythmic effect of ischemic preconditioning in rats involve the L-arginine nitric oxide pathway? J Caediovasc Pharmacol. 1995;25:524-530.
63. Woolfson RG, Patel VC, Neild GH, Yellon DM. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation. 1995;91:1545-1551.
64. Weselcouch EO, Baird AJ, Sleph P, Grover GJ. Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am J Physiol. 1995;268:H242-H249.
65. Bugge E, Ytrehus K. Bradykinin can protect against infarction but does not mediate ischemic preconditioning in the rat heart. Circulation. 1995;92(suppl I):I-456. Abstract.
66. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 1995;77:611-621.
67. Vegh A, Kaszala K, Papp JG, Parratt JR. Delayed myocardial protection by pacing-induced preconditioning; a possible role for bradykinin. Br J Pharmacol. 1995;116:288P. Abstract.
68. Balligand J-L, Kobzik L, Man X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, Michel T. Nitric oxide-dependent para-sympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem. 1995;270:14582-14586.
69. Belhassen L, Kelly RA, Smith TW, Balligand J-L. Nitric oxide synthase (NOS 3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. J Clin Invest. 1996;97:1908-1915.
70. Yellon DM, Latchman DS. Stress proteins and myocardial protection. J Moll Cell Cardiol. 1992;24:113-124.
71. Heads RJ, Baxter GF, Latchman DS, Yellon DM. Delayed protection in rabbit heart following ischaemic preconditioning is associated with modulation of HSP27 and superoxide dismutase at 24 hours. J Moll Cell Cardiol. 1995;27:A163. Abstract.
72. Tang XL, Qiu Y, Turrens JF, Sun JZ, Bolli R. Is late preconditioning against myocardial stunning mediated by increased endogenous antioxidant defenses? Circulation. 1996;94(suppl I):I-184. Abstract.
73. Pahl HL, Baeuerle PA. Oxygen and the control of gene expression Bioessays. 1994;16:497-502.
74. Das DK, Maulik N, Moraru II. Gene expression in acute myocardial stress: induction by hypoxia, ischemia, reperfusion, hyperthermia and oxidative stress. J Moll Cell Cardiol. 1995;27:181-193.
75. Kim S-J, Ghaleh B, Kudej RK, Hintze TH, Vatner SF. Brief periods of myocardial ischemia induce delayed upregulation of coronary vascular nitric oxide in conscious dogs. Circulation. 1996;94(suppl I):I-183. Abstract.
76. 2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci U S A. 1989;86: 6758-6762.
77. Downey JM, Cohen MV, Ytrehus K, Liu Y. Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C. In: Das DK, ed. Cellular Biochemical and Molecular Aspects of Reperfusion Injury. New York, NY: Annals of the Academy of Sciences; 1994;723:82-98.
78. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element: activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem. 1991;266:11632-11639.
79. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363-380.
80. Lander HM, Sehajpal P, Levine DM, Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxidegenerating compounds. J Immunol. 1993;150:1509-1516.
81. Haby C, Lisovoski F, Aunis D, Zwiller J. Stimulation of the cyclic GMP pathway by NO induces expression of the early genes c-fos and jun-B in PC-12 cells. J Neurochem. 1994;62:496-501.
82. Pilz RB, Suhasini M, Idriss S, Meinkoth JL, Boss GR. Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J. 1995;9:552-558.
83. Peunova N, Enikolopov G. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature. 1993;364: 450-453.
84. Maulik N, Engelman DT, Watanabe M, Engleman RM, Rousou JA, Flack JE, Deaton DW, Gorbunov NV, Elsayed NM, Kagan VE, Das DK. Nitric oxide/carbon monoxide: a molecular switch for myocardial preservation during ischemia. Circulation. 1996;94(suppl II):II-398-II-406.